HANSEN Pharmaceutical Soars to Limit‑Up on April 28, 2026 Amid Shenzhen’s Market Dip
HANSEN 002412’s limit‑up on April 28 reflects its robust, diversified drug portfolio and sector resilience, offering attractive upside amid a correcting market.
3 minutes to read